查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2028 年人胰島素製劑和輸送裝置全球市場規模調查，按藥物類型、裝置類型和地區預測
市場調查報告書
商品編碼
1131994

2022-2028 年人胰島素製劑和輸送裝置全球市場規模調查，按藥物類型、裝置類型和地區預測

Global Human Insulin Drugs and Delivery Devices Market Size study, by Drug Type, by Device Type and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球人用胰島素和輸送設備市場價值約為 403 億美元，預計在 2022-2028 年的預測期內以超過 3% 的健康增長率增長.

胰島素是一種蛋白質激素，有助於控制身體無法製造足夠胰島素的人的高血糖水平。胰島素通過促進脂肪組織和肌肉中的葡萄糖攝取來降低血糖水平。它可以注射到臀部、腹部、手臂後部或腿部。此外，胰島素不僅用於幫助控製糖尿病，還用於治療其直接後果，如糖尿病酮症酸中毒和高滲性高血□□糖。市場增長的主要因素包括糖尿病患者數量的增加和對 HI 類似物的市場需求不斷增長。根據聯邦基金的一項研究，與那些有醫療補助或私人保險的人相比，沒有保險的糖尿病患者使用更老、更便宜（且效果更差）的胰島素產品。 60% 到 80% 的未投保人為胰島素支付全價，相比之下，9% 的私人投保人和 3% 的 Medicaid 接受者支付全價。此外，關鍵 HI 藥物專利的預期到期將增加全球市場機會。然而，對產品批准的嚴格監管要求正在阻礙 2022-2028 年預測期內的市場增長。

在人胰島素製劑和輸送設備的全球市場研究中考慮的主要地區是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於糖尿病病例的數量不斷增加，北美在整體市場份額中處於領先地位。然而，由於人們生活方式的改變和不健康的飲食習慣，預計亞太地區將成為增長最快的地區。

本報告中包括的主要市場參與者是：

  • Novo Nordisk A/S
  • Insulet
  • Eli Lilly
  • Exir
  • Biocon
  • Becton Dickinson
  • Medtronic
  • Ypsomed
  • Julphar
  • Sanofi Aventis

本研究的目的是明確近年來各個細分市場和國家的市場規模，並預測未來八年的市場規模。該報告旨在包括所涵蓋的每個地區和國家的行業的定性和定量方面。此外，它還提供了有關關鍵方面的詳細信息，例如定義市場未來增長的驅動因素和挑戰。此外，該報告還應納入微觀市場中可供利益相關者投資的可用機會，以及對競爭格局和主要參與者的應用產品的深入分析。市場的詳細細分和子細分如下所述。

按藥物類型。

基礎或長效胰島素

推注或速效胰島素

常規人胰島素

結合胰島素

生物仿製藥胰島素

按設備類型

胰島素筆

胰島素泵

胰島素注射器

噴射噴射器

按地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

意大利

其他歐洲

亞太地區

中國

印度

日本

澳大利亞

韓國

其他亞太地區

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考慮的年份是：

實際年份 - 2018 年、2019 年、2020 年

2021 年基準年

預測期 - 2022 年 至 2028 年

本報告的目標受眾是全球人胰島素製劑和輸送設備市場。

主要諮詢公司和顧問

大公司、中型公司、中小企業

風險投資

增值經銷商 (VAR)

第三方知識提供者

投資銀行家

投資者

內容

第 1 章執行摘要

  • 市場快照
  • 2020-2028 年全球市場和細分市場估計和預測
    • 2020-2028 年人用胰島素和輸送設備市場：按地區分列
    • 2020-2028 年按藥物類型分列的人胰島素製劑和給藥裝置市場
    • 2020-2028 年按設備類型分列的人胰島素製劑和輸送設備市場
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章。人胰島素製劑和輸送設備全球市場的定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第 3 章人胰島素製劑和輸送裝置的全球市場動態

  • 人胰島素製劑和輸送裝置的市場影響分析（2020-2028 年）
    • 市場驅動力
      • 糖尿病患者人數增加
      • 市場對 HI 類似物的需求增加
    • 市場挑戰
      • 對產品批准的嚴格監管要求
    • 市場機會
      • 主要 HI 藥物的專利到期
      • 新興市場

第 4 章全球人用胰島素產品和輸送設備市場行業分析

  • 波特的 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
    • 波特 5 力模型的未來方法（2018-2028）
  • PEST 分析
    • 政治
    • 經濟
    • 社交
    • 技術
  • 招商引資模式
  • 分析師的結論和建議
  • 熱門投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

    • 評估 COVID-19 對行業的整體影響
    • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章。人類胰島素和輸送設備的全球市場：按藥物類型

  • 市場快照
  • 人胰島素製劑和遞送裝置的全球市場：按藥物類型、性能潛力分析
  • 2018-2028 年世界人用胰島素和遞送裝置市場、按藥物類型估計和預測
  • 人胰島素製劑和輸送設備市場，細分分析
    • 基礎胰島素或長效胰島素
    • 推注或速效胰島素製劑
    • 常規人胰島素
    • 複合胰島素
    • 生物仿製藥胰島素

第 7 章。按設備類型分列的人用胰島素和輸送設備全球市場

  • 市場快照
  • 人用胰島素和輸送設備的全球市場：按設備類型進行的性能潛力分析
  • 2018-2028 年全球人用胰島素和輸送設備市場、按設備類型估計和預測
  • 人胰島素製劑和輸送設備市場，細分分析
    • 胰島素筆
    • 胰島素泵
    • 胰島素注射器
    • 噴射噴射器

第 8 章全球人類胰島素和輸送設備市場：區域分析

  • 人胰島素製劑和輸送設備市場，按地區分列的市場快照
  • 北美
    • 美國
      • 按藥物類型劃分的估計和預測，2018-2028 年
      • 按設備類型劃分的估計和預測，2018-2028 年
    • 加拿大
  • 歐洲人胰島素製劑和輸送設備的市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區人用胰島素和輸送設備市場概覽
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲人胰島素和遞送設備市場快照
    • 巴西
    • 墨西哥
  • 世界其他地區

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Sanofi Aventis
      • 主要信息
      • 概覽
      • 財務（如果有數據）
      • 產品概覽
      • 近期發展狀況
    • Novo Nordisk A/S
    • Insulet
    • Eli Lilly
    • Exir
    • Biocon
    • Becton Dickinson
    • Medtronic
    • Ypsomed
    • Julphar

第十章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場估算
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Human Insulin Drugs and Delivery Devices Market is valued at approximately USD 40.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3% over the forecast period 2022-2028. Protein hormone insulin helps people whose systems are unable to manufacture enough insulin control high blood sugar levels. By enhancing glucose uptake in fatty tissues and muscles, insulin reduces the blood glucose level. This can be infused in buttocks, belly, backs of the arms, or legs. Additionally, insulin not only aids in the management of diabetes but also in the treatment of its immediate consequences, including diabetic ketoacidosis and hyperosmolar hyperglycemia. The market growth is driven by key factors such as growth in the number of diabetic patients and rising market demand for HI Analogs. According to a Commonwealth Fund study, Americans with diabetes who lack insurance are more likely to use older, less expensive (and less effective) insulin medications than those who have Medicaid or private insurance. 60% to 80% of people without insurance pay the entire list price for insulin, compared to 9% of privately insured patients and 3% of Medicaid recipients. Moreover, expected patent expiry of key HI Drugs propels the market opportunities across the globe. However, stringent regulatory requirements for product approval impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Human Insulin Drugs and Delivery Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to high cases and increasing amount of diabetic patients. However, Asia Pacific is expected to be the fastest growing region due to changing lifestyles of people and unhealthy dietary habits.

Major market players included in this report are:

Novo Nordisk A/S

Insulet

Eli Lilly

Exir

Biocon

Becton Dickinson

Medtronic

Ypsomed

Julphar

Sanofi Aventis

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Combination Insulins

Biosimilar Insulins

By Device Type:

Insulin Pens

Insulin Pumps

Insulin Syringes

Jet Injectors

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Human Insulin Drugs and Delivery Devices Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Human Insulin Drugs and Delivery Devices Market, by region, 2020-2028 (USD Billion)
    • 1.2.2. Human Insulin Drugs and Delivery Devices Market, by Drug Type, 2020-2028 (USD Billion)
    • 1.2.3. Human Insulin Drugs and Delivery Devices Market, by Device Type, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Insulin Drugs and Delivery Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Insulin Drugs and Delivery Devices Market Dynamics

  • 3.1. Human Insulin Drugs and Delivery Devices Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growth in the Number of Diabetic Patients
      • 3.1.1.2. Rising Market Demand for HI Analogs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent Regulatory Requirements for Product Approval
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Expected Patent Expiry of Key HI Drugs
      • 3.1.3.2. Emerging Markets

Chapter 4. Global Human Insulin Drugs and Delivery Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Human Insulin Drugs and Delivery Devices Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Human Insulin Drugs and Delivery Devices Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Drug Type, 2018-2028 (USD Billion)
  • 6.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
    • 6.4.1. Basal or Long-acting Insulins
    • 6.4.2. Bolus or Fast-acting Insulins
    • 6.4.3. Traditional Human Insulins
    • 6.4.4. Combination Insulins
    • 6.4.5. Biosimilar Insulins

Chapter 7. Global Human Insulin Drugs and Delivery Devices Market, by Device Type

  • 7.1. Market Snapshot
  • 7.2. Global Human Insulin Drugs and Delivery Devices Market by Device Type, Performance - Potential Analysis
  • 7.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Device Type, 2018-2028 (USD Billion)
  • 7.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
    • 7.4.1. Insulin Pens
    • 7.4.2. Insulin Pumps
    • 7.4.3. Insulin Syringes
    • 7.4.4. Jet Injectors

Chapter 8. Global Human Insulin Drugs and Delivery Devices Market, Regional Analysis

  • 8.1. Human Insulin Drugs and Delivery Devices Market, Regional Market Snapshot
  • 8.2. North America Human Insulin Drugs and Delivery Devices Market
    • 8.2.1. U.S. Human Insulin Drugs and Delivery Devices Market
      • 8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Device Type breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Human Insulin Drugs and Delivery Devices Market
  • 8.3. Europe Human Insulin Drugs and Delivery Devices Market Snapshot
    • 8.3.1. U.K. Human Insulin Drugs and Delivery Devices Market
    • 8.3.2. Germany Human Insulin Drugs and Delivery Devices Market
    • 8.3.3. France Human Insulin Drugs and Delivery Devices Market
    • 8.3.4. Spain Human Insulin Drugs and Delivery Devices Market
    • 8.3.5. Italy Human Insulin Drugs and Delivery Devices Market
    • 8.3.6. Rest of Europe Human Insulin Drugs and Delivery Devices Market
  • 8.4. Asia-Pacific Human Insulin Drugs and Delivery Devices Market Snapshot
    • 8.4.1. China Human Insulin Drugs and Delivery Devices Market
    • 8.4.2. India Human Insulin Drugs and Delivery Devices Market
    • 8.4.3. Japan Human Insulin Drugs and Delivery Devices Market
    • 8.4.4. Australia Human Insulin Drugs and Delivery Devices Market
    • 8.4.5. South Korea Human Insulin Drugs and Delivery Devices Market
    • 8.4.6. Rest of Asia Pacific Human Insulin Drugs and Delivery Devices Market
  • 8.5. Latin America Human Insulin Drugs and Delivery Devices Market Snapshot
    • 8.5.1. Brazil Human Insulin Drugs and Delivery Devices Market
    • 8.5.2. Mexico Human Insulin Drugs and Delivery Devices Market
  • 8.6. Rest of The World Human Insulin Drugs and Delivery Devices Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Sanofi Aventis
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Novo Nordisk A/S
    • 9.2.3. Insulet
    • 9.2.4. Eli Lilly
    • 9.2.5. Exir
    • 9.2.6. Biocon
    • 9.2.7. Becton Dickinson
    • 9.2.8. Medtronic
    • 9.2.9. Ypsomed
    • 9.2.10. Julphar

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Human Insulin Drugs and Delivery Devices Market, report scope
  • TABLE 2. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Drug Type 2018-2028 (USD Billion)
  • TABLE 4. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Device Type 2018-2028 (USD Billion)
  • TABLE 5. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 6. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 17. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 19. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 20. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 22. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 23. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 25. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 26. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 28. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 29. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 31. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 32. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 34. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 35. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 37. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 38. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 43. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 44. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 46. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 47. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 49. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 50. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 52. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 53. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
  • TABLE 55. List of primary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Human Insulin Drugs and Delivery Devices Market, research methodology
  • FIG 2. Global Human Insulin Drugs and Delivery Devices Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Human Insulin Drugs and Delivery Devices Market, key trends 2021
  • FIG 5. Global Human Insulin Drugs and Delivery Devices Market, growth prospects 2022-2028
  • FIG 6. Global Human Insulin Drugs and Delivery Devices Market, porters 5 force model
  • FIG 7. Global Human Insulin Drugs and Delivery Devices Market, pest analysis
  • FIG 8. Global Human Insulin Drugs and Delivery Devices Market, value chain analysis
  • FIG 9. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Human Insulin Drugs and Delivery Devices Market, regional snapshot 2018 & 2028
  • FIG 15. North America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia Pacific Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Human Insulin Drugs and Delivery Devices Market, company market share analysis (2021)